30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Nurx Pharmaceuticals Inc (NUXP)

Track

Stock chart
Ticker: NUXP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Baradaran Sharyar
1 purchase — total 50,000 USD
Buy 13 Oct 2009
Value US$2,022,536.14 | Price 418.87 | Shares 6,580
Buy 13 Oct 2009
Value US$21,826.38 | Price 154.31 | Shares 96,745
Sale 9 Oct 2009
Value US$100,000.00 | Price 0.25 | Shares 400,000
Sale 18 May 2009
Value US$239,922.76 | Price 0.22 | Shares 1,090,558
Buy 10 Mar 2008
Value US$52,250.00 | Price 0.55 | Shares 95,000
Sale 31 Aug 2007
Value US$1,875,000.00 | Price 0.75 | Shares 2,500,000
Sale 20 Oct 2006
Value US$32,300.00 | Price 0.02 | Shares 1,615,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2009-11-04 2009-10-13 B Purchase Baradaran Sharyar Non-Executive Director
6,580 +27.4%
418.87
US$2,022,536 		6,580 +27.4% 418.87 US$2,022,536
2009-11-04 2009-10-13 B Purchase Padma-Nathan Harin Non-Executive Director
96,745 +17.6%
154.31
US$21,826 		96,745 +17.6% 154.31 US$21,826
2010-02-24 2009-10-09 S Sale Santa Monica Capital Partners II, LLC Large shareholder
74,181 -16.1%
79.62
US$546,267 		74,181 -16.1% 79.62 US$546,267
2009-05-27 2009-05-18 S Sale Hunter World Markets, Inc. Large shareholder
1,090,558 -47.4%
0.22
US$239,923 		1,090,558 -47.4% 0.22 US$239,923
2008-03-28 2008-03-10 B Purchase Baradaran Sharyar Non-Executive Director
95,000 +19.0%
0.55
US$52,250 		95,000 +19.0% 0.55 US$52,250
2007-09-05 2007-08-31 S Sale Hunter World Markets, Inc. Large shareholder
2,500,000 -20.8%
0.75
US$1,875,000 		2,500,000 -20.8% 0.75 US$1,875,000
2006-10-24 2006-10-20 S Sale Davis Craig Alan

CEO

Executive Director
1,615,000 -61.2%
0.02
US$32,300 		1,615,000 -61.2% 0.02 US$32,300
Explore more

More insider trading research around Nurx Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America